McIlrath & Eck’s Usana Health Sciences USNA Stock Holding History

McIlrath & Eck’s Portfolio USNA Stock Details USNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$3.46K	Hold	198	–	–	﹤0.01%	1313
2025 Q4	$3.89K	Hold	198	–	–	﹤0.01%	812
2025 Q3	$5.46K	Hold	198	–	–	﹤0.01%	738
2025 Q2	$6.04K	Hold	198	–	–	﹤0.01%	694
2025 Q1	$5.34K	Hold	198	–	–	﹤0.01%	711
2024 Q4	$7.11K	Hold	198	–	–	﹤0.01%	685
2024 Q3	$7.51K	Hold	198	–	–	﹤0.01%	687
2024 Q2	$8.96K	Hold	198	–	–	﹤0.01%	626
2024 Q1	$9.6K	Hold	198	–	–	﹤0.01%	611
2023 Q4	$10.6K	Hold	198	–	–	﹤0.01%	546
2023 Q3	$11.6K	Hold	198	–	–	﹤0.01%	520
2023 Q2	$12.5K	Hold	198	–	–	﹤0.01%	519
2023 Q1	$12.5K	Hold	198	–	–	﹤0.01%	508
2022 Q4	$10.5K	Hold	198	–	–	﹤0.01%	521
2022 Q3	$11K	Hold	198	–	–	﹤0.01%	516
2022 Q2	$14K	Hold	198	–	–	﹤0.01%	453
2022 Q1	$16K	Hold	198	–	–	﹤0.01%	441
2021 Q4	$20K	Hold	198	–	–	0.01%	410
2021 Q3	$18K	Hold	198	–	–	0.01%	420
2021 Q2	$20K	Hold	198	–	–	0.01%	388
2021 Q1	$19K	Hold	198	–	–	0.01%	356
2020 Q4	$15K	Hold	198	–	–	0.01%	349
2020 Q3	$15K	Hold	198	–	–	0.01%	315
2020 Q2	$15K	Hold	198	–	–	0.01%	289
2020 Q1	$11K	Hold	198	–	–	0.01%	296
2019 Q4	$16K	Hold	198	–	–	0.01%	281
2019 Q3	$14K	Hold	198	–	–	0.01%	286
2019 Q2	$17K	Hold	198	–	–	0.01%	230
2019 Q1	$17K	Hold	198	–	–	0.01%	230
2018 Q4	$23K	Hold	198	–	–	0.01%	176
2018 Q3	$24K	Hold	198	–	–	0.01%	190
2018 Q2	$23K	Hold	198	–	–	0.01%	185
2018 Q1	$17K	Hold	198	–	–	0.01%	206
2017 Q4	$15K	Buy	+198	New	+$13.2K	0.01%	232

Other funds holding USNA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Pzena Investment Management New York $34.1B AUM 23.81% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

McIlrath & Eck's USNA Position: Q1 2026 in Review

McIlrath & Eck held its Usana Health Sciences (USNA) position steady in Q1 2026 at 198 shares worth $3.46K. The position accounts for ﹤0.01% of the portfolio, ranked #1313.

McIlrath & Eck first reported a position in USNA in Q4 2017 and has held it in 34 quarters since. The position peaked at $24K in Q3 2018. 139 funds tracked by Wall St. Rank hold USNA as of Q1 2026.

McIlrath & Eck held 198 shares of Usana Health Sciences worth $3.46K as of Q1 2026.
McIlrath & Eck left its Usana Health Sciences share count unchanged in Q1 2026.
Usana Health Sciences made up ﹤0.01% of McIlrath & Eck's portfolio in Q1 2026, its #1313 holding.
McIlrath & Eck first reported a position in Usana Health Sciences in Q4 2017 and has held it in 34 quarters since.
McIlrath & Eck's Usana Health Sciences position peaked at $24K in Q3 2018.
139 funds tracked by Wall St. Rank held Usana Health Sciences as of Q1 2026.

Based on McIlrath & Eck's 13F filing for Q1 2026, filed 19 May 2026.